Sorafenib for the treatment of unresectable hepatocellular carcinoma

por Furuse, Junji
Publicado 2008

A PARP inhibitor in pancreatic cancer: Enhancement anti-tumour activity of chemoradiation therapy against pancreatic cancer?

por Furuse, Junji
Publicado 2019

Paradigm Shifting of Systemic Chemotherapy for Unresectable Pancreatic Cancer in Japan

por Furuse, Junji
Publicado 2019

Targeted Therapy for Biliary Tract Cancer

por Furuse, Junji, Okusaka, Takuji
Publicado 2011

Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines

por Okusaka, Takuji, Furuse, Junji
Publicado 2020

Treatments for elderly cancer patients and reforms to social security systems in Japan

por Nagashima, Fumio, Furuse, Junji
Publicado 2022

Feasibility of Continuous Geriatric Assessments as a Prognostic Indicator in Elderly People with Gastrointestinal Cancer

por Kitamura, Hiroshi, Nagashima, Fumio, Andou, Masahiko, Furuse, Junji
Publicado 2019

The Prognostic Utility of a Geriatric Assessment for Patients with Pancreatic Cancer Receiving Gemcitabine-based Chemotherapy: A Prospective Observational Study

por Kitamura, Hiroshi, Nakazawa, Junichi, Nagashima, Fumio, Andou, Masahiko, Furuse, Junji
Publicado 2022

A pathological complete response after combined chemotherapy of gemcitabine and S-1 in advanced biliary tract cancer with para-aortic lymph nodes metastasis: a case report

por Watanabe, Takeshi, Furuse, Junji, Okano, Naohiro, Suzuki, Yutaka, Kamma, Hiroshi, Sugiyama, Masanori
Publicado 2017

Postmarketing surveillance study of erlotinib plus gemcitabine for pancreatic cancer in Japan: POLARIS final analysis

por Furuse, Junji, Gemma, Akihiko, Ichikawa, Wataru, Okusaka, Takuji, Seki, Akihiro, Ishii, Tadashi
Publicado 2017

Tramadol/Acetaminophen Combination Tablets in Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy: A Single-Arm Phase II Study

por Naruge, Daisuke, Nagashima, Fumio, Kawai, Kirio, Okano, Naohiro, Kobayashi, Takaaki, Furuse, Junji
Publicado 2020

Current status of medical treatment for gastroenteropancreatic neuroendocrine neoplasms and future perspectives

por Hijioka, Susumu, Morizane, Chigusa, Ikeda, Masafumi, Ishii, Hiroshi, Okusaka, Takuji, Furuse, Junji
Publicado 2021

Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case report

por Matsuki, Ryota, Sugiyama, Masanori, Takei, Hidefumi, Kondo, Haruhiko, Fujiwara, Masachika, Shibahara, Junji, Furuse, Junji
Publicado 2018

Liposomal irinotecan with fluorouracil and leucovorin after gemcitabine-based therapy in Japanese patients with metastatic pancreatic cancer: additional safety analysis of a random...

por Furuse, Junji, Ueno, Makoto, Ikeda, Masafumi, Okusaka, Takuji, Teng, Zhaoyang, Furuya, Momoko, Ioka, Tatsuya
Publicado 2022

Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer

por Okusaka, Takuji, Ikeda, Masafumi, Fukutomi, Akira, Ioka, Tatsuya, Furuse, Junji, Ohkawa, Shinichi, Isayama, Hiroyuki, Boku, Narikazu
Publicado 2014

Response to Y. Sasaki et al.: Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer?

por Okusaka, Takuji, Ikeda, Masafumi, Fukutomi, Akira, Ioka, Tatsuya, Furuse, Junji, Ohkawa, Shinichi, Isayama, Hiroyuki, Boku, Narikazu
Publicado 2015

Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan

por Furuse, Junji, Izumi, Namiki, Motomura, Kenta, Inaba, Yoshitaka, Katamura, Yoshio, Kondo, Yasuteru, Yabushita, Kazuhisa, Motoyoshi, Katsuaki, Kudo, Masatoshi
Publicado 2023

Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinoma

por Ikeda, Masafumi, Ohkawa, Shinichi, Okusaka, Takuji, Mitsunaga, Shuichi, Kobayashi, Satoshi, Morizane, Chigusa, Suzuki, Ikue, Yamamoto, Shunsuke, Furuse, Junji
Publicado 2014

KRAS Mutation as a Potential Prognostic Biomarker of Biliary Tract Cancers

por Yokoyama, Masaaki, Ohnishi, Hiroaki, Ohtsuka, Kouki, Matsushima, Satsuki, Ohkura, Yasuo, Furuse, Junji, Watanabe, Takashi, Mori, Toshiyuki, Sugiyama, Masanori
Publicado 2016

Efficacy and safety of gemcitabine plus S-1 in pancreatic cancer: a pooled analysis of individual patient data

por Hamada, Chikuma, Okusaka, Takuji, Ikari, Takaaki, Isayama, Hiroyuki, Furuse, Junji, Ishii, Hiroshi, Nakai, Yousuke, Imai, Shogo, Okamura, Shota
Publicado 2017